| Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats MG Leonard, A Gulati Brain research 1528, 28-41, 2013 | 66 | 2013 |
| Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats MG Leonard, S Briyal, A Gulati Brain research 1420, 48-58, 2011 | 58 | 2011 |
| Stimulation of endothelin B receptors by IRL-1620 decreases the progression of Alzheimer’s disease S Briyal, C Nguyen, M Leonard, A Gulati Neuroscience 301, 1-11, 2015 | 53 | 2015 |
| Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats MG Leonard, S Briyal, A Gulati Brain research 1464, 14-23, 2012 | 51 | 2012 |
| A Novel Neuroregenerative Approach Using ETB Receptor Agonist, IRL-1620, to Treat CNS Disorders. A Gulati, MG Hornick, S Briyal, MS Lavhale Physiological research 67, 2018 | 32 | 2018 |
| Selective endothelin-B receptor stimulation increases vascular endothelial growth factor in the rat brain during postnatal development MG Leonard, P Prazad, B Puppala, A Gulati Drug research, 607-613, 2015 | 27 | 2015 |
| Anti-apoptotic activity of ETB receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia S Briyal, AK Ranjan, MG Hornick, AK Puppala, T Luu, A Gulati Scientific reports 9 (1), 10439, 2019 | 22 | 2019 |
| Prenatal oxycodone exposure alters CNS endothelin receptor expression in neonatal rats M Devarapalli, M Leonard, S Briyal, G Stefanov, BL Puppala, L Schweig, ... Drug Research 66 (05), 246-250, 2016 | 20 | 2016 |
| Repeated administration of ETB receptor agonist, IRL-1620, produces tachyphylaxis only to its hypotensive effect MG Leonard, A Gulati Pharmacological research 60 (5), 402-410, 2009 | 18 | 2009 |
| Ontogeny of endothelin receptors in the brain, heart, and kidneys of neonatal rats B Puppala, I Awan, S Briyal, O Mbachu, M Leonard, A Gulati Brain and Development 37 (2), 206-215, 2015 | 17 | 2015 |
| Maternal cannabinoid use alters cannabinoid (CB1) and endothelin (ETB) receptor expression in the brains of dams but not their offspring A Amlani, MG Hornick, K Cooper, P Prazad, R Donovan, A Gulati Developmental Neuroscience 39 (6), 498-506, 2017 | 11 | 2017 |
| Neuroprotective effect of IRL-1620, an endothelin B receptor agonist, on a pediatric rat model of middle cerebral artery occlusion EG Cifuentes, MG Hornick, S Havalad, RL Donovan, A Gulati Frontiers in Pediatrics 6, 310, 2018 | 10 | 2018 |
| SARS-CoV-2 psychiatric sequelae: a review of neuroendocrine mechanisms and therapeutic strategies MG Hornick, ME Olson, AL Jadhav International Journal of Neuropsychopharmacology 25 (1), 1-12, 2022 | 9 | 2022 |
| Distinct alteration in brain endothelin A and B receptor characteristics following focal cerebral ischemia in rats S Bhalla, MG Leonard, S Briyal, A Gulati Drug Research 66 (04), 189-195, 2016 | 8 | 2016 |
| Anti-apoptotic and immunomodulatory effect of CB2 agonist, JWH133, in a neonatal rat model of hypoxic-ischemic encephalopathy B Gupta, MG Hornick, S Briyal, R Donovan, P Prazad, A Gulati Frontiers in pediatrics 8, 65, 2020 | 7 | 2020 |
| Centhaquin attenuates hyperalgesia and non-evoked guarding in a rat model of postoperative pain primarily through α2B-adrenoceptors MG Leonard, S Jung, SV Andurkar, A Gulati European Journal of Pharmacology 789, 81-87, 2016 | 6 | 2016 |
| A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects ME Olson, MG Hornick, A Stefanski, HR Albanna, A Gjoni, GD Hall, ... Frontiers in Immunology 14, 1264383, 2023 | 4 | 2023 |
| Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder. MG Hornick, A Stefanski Frontiers in Pharmacology 14, 1221719, 2023 | 2 | 2023 |
| Modulation of Apoptotic Pathway by Etb Receptor Agonist, Irl-1620, in Rats With Cerebral Ischemia A Gulati, S Briyal, MG Hornick, E Cifuentes, AK Puppala, L Thanh, ... Circulation 136 (suppl_1), A20684-A20684, 2017 | 1 | 2017 |
| 724: EFFECT OF IRL-1620, AN ENDOTHELIN-B RECEPTOR AGONIST, ON ISCHEMIC STROKE IN A PEDIATRIC RAT MODEL M Leonard, E Cifuentes, S Havalad, R Donovan, A Gulati Critical Care Medicine 44 (12), 257, 2016 | | 2016 |
Anil GulatiChairman and CEO, Pharmazz, Inc.在 pharmazz.com 的电子邮件经过验证
